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ABSTRACT  
Objective: The literature survey revealed that various methods are reported for determination of Irbesartan and Hydrochlorothiazide alone or in 
combination with other drugs So, the main objective of our study was to develop simple, accurate and reproducible methods for the simultaneous 
estimation of Irbesartan and Hydrochlorothiazide in a combined dosage form. 
Methods: The method for the simultaneous determination of Irbesartan and Hydrochlorothiazide by spectroscopy has been developed. The simple, 
accurate and precise method includes Area Under the Curve (AUC) method. On response to the effect of solvent on spectral behaviors of Irbesartan 
and Hydrochlorothiazide, methanol was selected as solvent. Irbesartan shows maximum absorbance at 224 nm and Hydrochlorothiazide shows 
maximum absorbance at 271 nm. For the AUC method, the wavelength ranges between 225-230 nm and 258-265 nm respectively were selected 
with reference to the absorbance curves plotted between the wavelengths of 200-400 nm. This method allows rapid analysis of two drug 
combinations.  
Results: The result of analysis was validated statistically by recovery study following ICH method validation guideline. Tablet containing both drugs 
was assayed using the method developed, showing a good accuracy and precision. 
Conclusion: It can therefore be concluded that use of this method can save more time and money and it can be used in small laboratories with 
accuracy 
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INTRODUCTION 
Irbesartan (fig. 1) and Hydrochlorothiazide (fig. 2) are the 
combination angiotensin II receptor blocker and diuretic. The 
angiotensin II receptor blocker works by relaxing the blood vessels. 
The effect of diuretics on lowering the blood pressure is still unknown, 
but it helps the kidneys to eliminate fluid and sodium from the body. 
Irbesartan (Irb) is a non-peptide compound, chemically described as a 2-
butyl-3-[p-(o-1H-tetrazol-5-ylphenyl) benzyl]-1,3-diazaspiro[4.4] non-1-
en-4-one. Its empirical formula is C25H28N6
A hydrochlorthiazide (HCTZ; fig. 2) diuretic often considered as the 
prototypical member of this class. It reduces the re-absorption of 
electrolytes from the renal tubules. Thus results in increased 
excretion of water and electrolytes, including sodium, potassium, 
chloride, and magnesium. It has been used in the treatment of 
several disorders including edema, hypertension, diabetes insipidus, 
and hypoparathyroidism. (14) 
  
O, and its structural formula 




Fig. 1: chemical structure of Irbesartan Fig. 2: Chemical structure of Hydrochlorthiazide 
 
Many analytical methods like HPLC, capillary electrophoresis and UV 
spectroscopy (7-10) were reported for determination of Irb and HCTZ 
(11-13) in combination. However, no area under curve spectro 
photometric method is reported for simultaneous determination of 
these drugs. In this communication, we report a new UV spectro 
photometric method using area under curve spectroscopy. 
MATERIALS AND METHODS 
Instruments  
A UV Probe type UV-VIS double beam spectrophotometer (shimadzu 
1800) with 1 cm Quartz cells was used in this experiment. Analysis 
was performed using direct mode over a wavelength range from 
200-400 nm. The instrument settings were zero order and first 
derivative mode and band width of 2 nm in the range of 200-400 
nm. All weights were taken on an electronic balance. 
Reagents and chemicals 
Irbesartan, working standard was obtained as a gift sample from 
Sanofi Aventis (Goa) and Hydrochlorothiazide, as a gift sample from 
CTX Life Sciences Pvt Ltd. Methanol (Spectrochem Chemicals) and 
Irbesartan and Hydrochlorothiazide combination tablet (Irovel-H, 
Sun pharma) were purchased from local market. 
Preparation of standard stock solutions 
10 mg each of standard Irbesartan and Hydrochlorothiazide were 
weighed and transferred to two separate 100 ml volumetric flasks and 
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dissolved in methanol (98 % v/v) and further diluted with the methanol 
to get the standard solutions Irb and HCTZ of 100.0 μg ml-1each. 
Method: Area under curve method 
In the simultaneous equation using AUC method, the area under 
curves of the spectrums were measured at the selected wavelength 
ranges, 225-230 nm and 258-265 nm and calibration curves were 
plotted by taking concentration on x-axis and AUC at 225-230 nm 
and 258-265 nm on Y-axis. The ‘X’ values were determined as, X= 
Area under curve of component (from 225-230 nm and 258-265). A 
set of two simultaneous equations of Irbesartan and 
Hydrochlorothiazide using these ‘X’ values as follows, 
A1=0.0010Cirbi+0.0442Chctz----- (at λ 225.0-230.0 nm)-(1) 
A2=0.0004 Cirbe+0.0011 Chctz--------------- (at λ 258.0-265.0 nm)-(2) 
Where, CIrb and CHCTZ are the concentrations of Irb and HCTZ 
measured in μg/ml, in the sample solutions. A1 and A2
For all the methods, 6-point (2-20 μgml
 are the area 
under curve of sample solutions at the wavelength ranges from 225-
230 nm and 258-265 nm, respectively. 
Preparation of tablet sample solution 
Twenty tablets of IROVEL-H each containing Irb (150 mg) and HCTZ 
(12.5 mg) were weighed and crushed to fine powder. An accurately 
weighed powder sample equivalent to 150 mg of Irb and 12.5 mg 
HCTZ was transferred to a 100 ml conical flask. These were 
extracted with methanol (4 x 20 ml) and the solution was sonicated 
for 30 min and volume was made up to the mark with methanol in a 
100 ml calibrated volumetric flask, the solution was filtered through 
Whatman filter paper. 1.0 ml of this solution was pipetted out and 
transferred to 100 ml calibrated volumetric flask and volume was 
made up to the mark with methanol to obtain a concentration of 15 
µg/ml for Irb and 1.25 µg/ml for HCTZ. After appropriate dilutions, 
the absorbances were measured and the concentration of each 
analyte was determined with the equations generated from the 
calibration curve for respective drugs. The developed method was 
validated by following ICH Q2B (R1) guidelines. The following 
parameter were studied for validation. 
Validation of methods 
Linearity 
-1 Irb and 0.5-10 μgml-1
Accuracy 
 HCTZ 
to calculate the equation of the line by using the least-squares 
regression method. 
Recovery study was performed by standard addition method at 
three levels i.e., 80%, 100% and 120%. Known amounts of pure 
Irbesartan and HCTZ were added to pre-analyzed sample of 
marketed formulation and they were subjected to analysis by the 
proposed method. A result of recovery study is shown in table 1. 
Precision 
Precision study was performed to find out intra-day and inter-day 
variations. The results of precision studies are reported in table 2 
and values of standard deviation less than 2% indicates high degree 
of precision. 
Limit of Detection (LOD) and Limit of Quantitation (LOQ) 
The LOD and LOQ were separately determined based on the 
calibration curves. The standard deviation of the y-intercepts (σ) 
and slope of the regression lines (S) were used. These values were 
calculated using following formula 
LOD = 3.3 × σ/S LOQ = 10 × σ/S 
Ruggedness 
Ruggedness of the proposed methods was determined by 
analyzing aliquots from homogenous slot in different 




Fig. 3: Overlay spectra of Irbesartan and Hydrochlorothiazide. 
 
Table 1: Results of recovery study 
Drug % 
added 




Amt recovered SD %RSD %recovery SD %RSD 
 80 6 4.8 10.8 10.7066 0.085 0.787 99.1352 0.3251 0.328 
Irb 100 6 6 12 12.0100 0.0665 0.5536 100.083 0.5548 0.5536 
 120 6 7.2 13.2  12.9866 0.1209 0.9365 98.3833 1.7637 1.7746 
 80 4 3.2 7.2 7.1966 0.0757 1.0699 99.9528 1.0516 1.0521 
HCTZ 100 4 4 8 7.9833 0.1209 1.5152 99.7913 1.5121 1.5152 
 120  4  4.8  8.8  8.8036 0.0151 0.1723 100.041 0.1723 0.1722 
 
Table 2: Precision study 
Conc(µg/ml) intraday  interday  
Irbe mean conc±SD %RSD mean conc±SD %RSD 
4  3.99±.0503 1.2593 3.95±0.0608 1.5399 
10 10.0933±.1096 1.0868 9.966±0.0611 0.6139 
18  18.06±.1708 0.9461 17.96±0.13 0.7238 
 HCTZ     
1 0.9904±.0094 0.9507 0.9863±.0030 0.3045 
4 3.9866±.0351 0.8809 3.9666±.0550 1.3884 
10 10.01±.0200 0.1998 9.970±0.0624 0.6251 
  
RESULTS AND DISCUSSION 
The proposed method for simultaneous estimation using AUC of Irb 
and HCTZ in combined dosage form was found to be accurate, 
simple and rapid. Hence, it can be used for routine analysis of two 
drugs in the combined dosage forms. There was no interference 
from tablet excipients was observed in these methods. The values of 
% RSD for simultaneous determination (Tablet) were found to be 
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(0.274-1.25), (0.2214-1.11 %) for Irb and HCTZ and correlation 
coefficient was 0.999. The result of recovery studies for tablet was 
found to be in the range of 98.38-100.83, 99.740-100.04 % for Irb and 
HCTZ respectively. Values are reported in table 1. It indicates that there 
is no interference due to excipients present in the formulation. It can be 
easily and conveniently adopted for routine quality control analysis. This 
method is accurate, simple, rapid, precise, reliable, sensitive, 
reproducible, economic and validated as per ICH guidelines. 
CONCLUSION 
The results of above mentioned study indicate that the proposed UV 
spectroscopic method is simple, rapid, precise and accurate. The 
developed UV spectroscopic method was found suitable for 
determination of Irb and HCTZ as bulk drug and in marketed solid 
dosage formulation without any interference from the excipients. 
Statistical analysis proves that this method was repeatable and 
selective for the analysis of Irb and HCTZ. It can therefore be 
concluded that use of this method can save more time and money 
and it can be used in small laboratories with accuracy. 
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